EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Multimodal AI Framework for Automated Multiclass Lung Disease Diagnosis from Respiratory Sounds with Simulated Biomarker Fusion and Personalized Medication Recommendation

Abdullah iD, Zulaikha Fatima iD, Jawad Abdullah iD, José Luis Oropeza Rodríguez iD, Grigori Sidorov iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26157135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Abdullah und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Computing Research, Instituto Politécnico Nacional, Mexico City 07738, Mexico. Hauptthemen laut MEDLINE: Respiratory Sounds, Biomarkers, Precision Medicine, Lung Diseases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory diseases represent a persistent global health challenge, underscoring the need for intelligent, accurate, and personalized diagnostic and therapeutic systems. Existing methods frequently suffer from limitations in diagnostic precision, lack of individualized treatment, and constrained adaptability to complex clinical scenarios. To address these challenges, our study introduces a modular AI-powered framework that integrates an audio-based disease classification model with simulated molecular biomarker profiles to evaluate the feasibility of future multimodal diagnostic extensions, alongside a synthetic-data-driven prescription recommendation engine. The disease classification model analyzes respiratory sound recordings and accurately distinguishes among eight clinical classes: bronchiectasis, pneumonia, upper respiratory tract infection (URTI), lower respiratory tract infection (LRTI), asthma, chronic obstructive pulmonary disease (COPD), bronchiolitis, and healthy respiratory state. The proposed model achieved a classification accuracy of 99.99% on a holdout test set, including 94.2% accuracy on pediatric samples. In parallel, the prescription module provides individualized treatment recommendations comprising drug, dosage, and frequency trained on a carefully constructed synthetic dataset designed to emulate real-world prescribing logic.The model achieved over 99% accuracy in medication prediction tasks, outperforming baseline models such as those discussed in research. Minimal misclassification in the confusion matrix and strong clinician agreement on 200 prescriptions (Cohen’s κ = 0.91 [0.87–0.94] for drug selection, 0.78 [0.74–0.81] for dosage, 0.96 [0.93–0.98] for frequency) further affirm the system’s reliability. Adjusted clinician disagreement rates were 2.7% (drug), 6.4% (dosage), and 1.5% (frequency). SHAP analysis identified age and smoking as key predictors, enhancing model explainability. Dosage accuracy was 91.3%, and most disagreements occurred in renal-impaired and pediatric cases. However, our study is presented strictly as a proof-of-concept. The use of synthetic data and the absence of access to real patient records constitute key limitations. A trialed clinical deployment was conducted under a controlled environment with a positive rate of satisfaction from experts and users, but the proposed system must undergo extensive validation with de-identified electronic medical records (EMRs) and regulatory scrutiny before it can be considered for practical application. Nonetheless, the findings offer a promising foundation for the future development of clinically viable AI-assisted respiratory care tools.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory SoundsBiomarkersPrecision MedicineLung DiseasesArtificial IntelligenceHumansChildMaleAdultFemaleMiddle AgedChild, Preschool

Stichwörter der Autor:innen

COPDasthmaattention-based prescription modelingaudio-based diagnosisbiomarker simulationclinical decision support system (CDSS)deep learninglung disease classificationmolecular feature fusionmultimodal AIpersonalized medication recommendationpneumoniaprecision healthcarerespiratory sound analysissynthetic medical data

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Center for Computing Research, Instituto Politécnico Nacional, Mexico City 07738, Mexico.
  • Department of Computer Sciences, Bahria University, Lahore 54600, Pakistan.
  • Faculty of Allied Health Sciences, Superior University, Lahore Campus, Lahore 54000, Pakistan.

ORCID-Profile: Abdullah, Zulaikha Fatima, Jawad Abdullah, José Luis Oropeza Rodríguez, Grigori Sidorov

Zitieren

APA

Abdullah, Fatima, Z., Abdullah, J., Rodríguez, J. L. O., & Sidorov, G. (2025). A Multimodal AI Framework for Automated Multiclass Lung Disease Diagnosis from Respiratory Sounds with Simulated Biomarker Fusion and Personalized Medication Recommendation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157135

Vancouver

Abdullah, Fatima Z, Abdullah J, Rodríguez JLO, Sidorov G. A Multimodal AI Framework for Automated Multiclass Lung Disease Diagnosis from Respiratory Sounds with Simulated Biomarker Fusion and Personalized Medication Recommendation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157135

BibTeX
@article{Abdullah2025,
  author = {Abdullah and Fatima, Zulaikha and Abdullah, Jawad and Rodríguez, José Luis Oropeza and Sidorov, Grigori},
  title = {A Multimodal AI Framework for Automated Multiclass Lung Disease Diagnosis from Respiratory Sounds with Simulated Biomarker Fusion and Personalized Medication Recommendation},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26157135}
}
Kostenlos starten →